Unknown

Dataset Information

0

The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center.


ABSTRACT: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition attributed to pathogenic variants in fumarate hydratase (FH) and presents with cutaneous leiomyomas (CLMs), uterine leiomyomas (ULMs) and renal cell cancer (RCC). The objective of this study was to characterize the spectrum of clinical and genetic findings in HLRCC at a large academic tertiary care referral center with a focus on dermatologic manifestations. Fifty-seven patients, 41 female and 16 male, with 27 unique pathogenic or likely-pathogenic FH variants were identified from 38 families. Mean age of HLRCC diagnosis was 44.4 years (range 8-82). CLMs were the primary reason for referral in 49.1% (n=28). CLMs were present in 43/56 patients who underwent full skin examination. Three of these 56 patients were diagnosed with cutaneous leiomyosarcoma. Incidence of ULMs was 37/41 female patients; no uterine leiomyosarcomas were observed. RCC was observed in 6/57 patients (mean age of diagnosis: 47.3 years (range 28-79)). CLMs predated RCC in the 3 patients diagnosed with both. Dermatologists have an opportunity to recognize cutaneous manifestations of HLRCC, including cutaneous leiomyomas and rarely cutaneous leiomyosarcomas, and refer for genetic evaluation to provide definitive diagnosis. Identification of HLRCC can promote family cascade testing and screening for RCC.

SUBMITTER: Scharnitz T 

PROVIDER: S-EPMC9906083 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center.

Scharnitz Thomas T   Nakamura Mio M   Koeppe Erika E   Henry Marie-Louise ML   Lowe Lori L   Else Tobias T   Cha Kelly B KB  

American journal of cancer research 20230115 1


Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition attributed to pathogenic variants in <i>fumarate hydratase</i> (<i>FH</i>) and presents with cutaneous leiomyomas (CLMs), uterine leiomyomas (ULMs) and renal cell cancer (RCC). The objective of this study was to characterize the spectrum of clinical and genetic findings in HLRCC at a large academic tertiary care referral center with a focus on dermatologic manifestations. Fifty-seven patients, 41 female an  ...[more]

Similar Datasets

| S-EPMC4574691 | biostudies-literature
| S-EPMC10681094 | biostudies-literature
| S-EPMC8554149 | biostudies-literature
| S-EPMC10226371 | biostudies-literature
| S-EPMC7648897 | biostudies-literature
| S-EPMC8490290 | biostudies-literature
2022-09-20 | GSE211577 | GEO
| S-EPMC10048779 | biostudies-literature
| S-EPMC4074185 | biostudies-literature
| S-EPMC10048203 | biostudies-literature